[1]JournalofMedicinalChemistry,2017,vol.60,p.1343-1361
[2]Patent:WO2017/31255,2017,A1.Locationinpatent:Paragraph00100
[3]ChemischeBerichte,1885,vol.18,p.2603
162100-56-3
3033-82-7
941294-27-5
19655-46-0
41037-29-0
63136-61-8
58123-57-2 | C-Quinolin-5-yl-methylamine | AA00E9VT | MFCD06738976
6046-42-0 | 4-QUINOLINESULFONIC ACID | AA00E9ZL | MFCD03426331
650592-73-7 | 2-Chloro-N-(6-methyl-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)acetamide | AA00EA6A | MFCD03941358
62667-25-8 | Benzooxazole-2-carbaldehyde | AA00EACB | MFCD03412586
58962-34-8 | 6-KETO-PROSTAGLANDIN F1ALPHA | AA00EAI4 | MFCD00135222
60846-91-5 | (S)-3-N-Cbz-amino-succinimide | AA00EANH | MFCD05864630
56545-53-0 | 3-Acetylamino-1h-indole-2-carboxylic acid | AA00EATS | MFCD00997483
617-92-5 | N-ETHYLPYRROLE | AA00EB0G | MFCD00060633
58952-14-0 | 3,4-DIMETHOXY-THIOBENZAMIDE | AA00EB6X | MFCD04973329
61033-04-3 | 6-AMINO-5-NITROSO-3-METHYLURACIL | AA00EBDM | MFCD03425482
